مجلة دراسات وأبحاث اقتصادية في الطاقات المتجددة
Volume 10, Numéro 2, Pages 84-101
2024-01-15
Merger And Acquisition As A Strategy To Improve Competitive Advantage: Evidence From Pfizer (2000-2022)
Authors : Sahraoui Zoubeida . Benchiha Kada Hichem .
Abstract
The research paper aims to analyze and determine the effectiveness of merger and acquisition as a strategy to improve economic companies’ competitive advantage, exclusively the pharmaceutical sector, through the case study of Pfizer, by analyzing and interpreting the financial performance of the company, using the annuals reports from its official website from 2000 until 2022. The study concluded that Pfizer benefited greatly from this strategy, which is evident through the increase in its financial indicators, and that it achieved great success, especially in recent years, despite the economic recession that the world suffered from. In addition its success is primaly due to competent team an expert board capable to make decisions that are often right, most notably an expansionist policy based on merger and acquisition strategy which has proven its worth in imporving and developping the competitive advantage of this firm.
Keywords
Merger ; Impact ; Financial Performance ; Pharmaceutical sector ; Pfizer
Les articles similaires
Zehar Assia
.
Benmansour Moussa
.
pages 88-99.
Kerouani Meriem
.
Habbache Fares
.
pages 605-622.
Fattouche Soumeya
.
Hedjazi Ismail
.
pages 727-744.
بن عبود شادية
.
عبد المجيد أونيس
.
pages 777-795.
Sahraoui Zoubeida
.
Benchiha Kada Hichem
.
pages 134-146.
